BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,782 | -25.7% | 1,955 | -10.3% | 0.01% | -25.0% |
| Q2 2023 | $99,321 | +5.1% | 2,180 | -6.4% | 0.01% | 0.0% |
| Q1 2023 | $94,505 | +79316.0% | 2,330 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $119 | -99.9% | 2,330 | 0.0% | 0.02% | -11.1% |
| Q3 2022 | $125,000 | -16.7% | 2,330 | 0.0% | 0.02% | -10.0% |
| Q2 2022 | $150,000 | -16.7% | 2,330 | 0.0% | 0.02% | -9.1% |
| Q1 2022 | $180,000 | -10.0% | 2,330 | 0.0% | 0.02% | -8.3% |
| Q4 2021 | $200,000 | +6.4% | 2,330 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $188,000 | 0.0% | 2,330 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $188,000 | -4.1% | 2,330 | 0.0% | 0.02% | -7.7% |
| Q1 2021 | $196,000 | +4.8% | 2,330 | 0.0% | 0.03% | -27.8% |
| Q4 2020 | $187,000 | -0.5% | 2,330 | 0.0% | 0.04% | -10.0% |
| Q3 2020 | $188,000 | -8.3% | 2,330 | -2.1% | 0.04% | -11.1% |
| Q2 2020 | $205,000 | +3.0% | 2,380 | -3.1% | 0.04% | -4.3% |
| Q1 2020 | $199,000 | -2.9% | 2,455 | 0.0% | 0.05% | +17.5% |
| Q4 2019 | $205,000 | -37.3% | 2,455 | -34.4% | 0.04% | -41.2% |
| Q3 2019 | $327,000 | +2.5% | 3,740 | -3.9% | 0.07% | -1.4% |
| Q2 2019 | $319,000 | +0.6% | 3,890 | 0.0% | 0.07% | -5.5% |
| Q1 2019 | $317,000 | +22.4% | 3,890 | -1.3% | 0.07% | +10.6% |
| Q4 2018 | $259,000 | -18.3% | 3,940 | -4.1% | 0.07% | -1.5% |
| Q3 2018 | $317,000 | +4.6% | 4,110 | 0.0% | 0.07% | -1.5% |
| Q2 2018 | $303,000 | +13.5% | 4,110 | 0.0% | 0.07% | +9.7% |
| Q1 2018 | $267,000 | +2.3% | 4,110 | +2.1% | 0.06% | +3.3% |
| Q4 2017 | $261,000 | +8.8% | 4,025 | +5.4% | 0.06% | +5.3% |
| Q3 2017 | $240,000 | +3.9% | 3,820 | 0.0% | 0.06% | +3.6% |
| Q2 2017 | $231,000 | +16.7% | 3,820 | 0.0% | 0.06% | +14.6% |
| Q1 2017 | $198,000 | +20.0% | 3,820 | +2.6% | 0.05% | +17.1% |
| Q4 2016 | $165,000 | -1.8% | 3,725 | +5.7% | 0.04% | -4.7% |
| Q3 2016 | $168,000 | -4.5% | 3,525 | -9.0% | 0.04% | -6.5% |
| Q2 2016 | $176,000 | +10.7% | 3,875 | 0.0% | 0.05% | +9.5% |
| Q1 2016 | $159,000 | +7.4% | 3,875 | 0.0% | 0.04% | +5.0% |
| Q4 2015 | $148,000 | +16.5% | 3,875 | 0.0% | 0.04% | +11.1% |
| Q3 2015 | $127,000 | -46.2% | 3,875 | +14.8% | 0.04% | -43.8% |
| Q2 2015 | $236,000 | -4.1% | 3,375 | -5.9% | 0.06% | -3.0% |
| Q1 2015 | $246,000 | -15.8% | 3,588 | -10.0% | 0.07% | -17.5% |
| Q4 2014 | $292,000 | +0.3% | 3,988 | -1.4% | 0.08% | -1.2% |
| Q3 2014 | $291,000 | -14.9% | 4,043 | -14.3% | 0.08% | -12.0% |
| Q2 2014 | $342,000 | +4.6% | 4,718 | +6.2% | 0.09% | -1.1% |
| Q1 2014 | $327,000 | -0.9% | 4,443 | -6.3% | 0.09% | -2.1% |
| Q4 2013 | $330,000 | -11.3% | 4,743 | -16.3% | 0.10% | -16.7% |
| Q3 2013 | $372,000 | -10.8% | 5,668 | -5.7% | 0.11% | -14.9% |
| Q2 2013 | $417,000 | – | 6,013 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |